Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-012932
Filing Date
2019-10-31
Accepted
2019-10-31 12:26:10
Documents
103
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q akorn10q-09302019.htm   iXBRL 10-Q 2214454
2 EXHIBIT 31.1 exhibit311-09302019.htm EX-31.1 9830
3 EXHIBIT 31.2 exhibit312-09302019.htm EX-31.2 9877
4 EXHIBIT 32.1 exhibit321-09302019.htm EX-32.1 5157
5 EXHIBIT 32.2 exhibit322-09302019.htm EX-32.2 4996
  Complete submission text file 0001628280-19-012932.txt   11757900

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT akrx-20190930.xsd EX-101.SCH 79640
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT akrx-20190930_cal.xml EX-101.CAL 130497
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT akrx-20190930_def.xml EX-101.DEF 323139
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT akrx-20190930_lab.xml EX-101.LAB 1012923
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT akrx-20190930_pre.xml EX-101.PRE 590062
57 EXTRACTED XBRL INSTANCE DOCUMENT akorn10q-09302019_htm.xml XML 2427449
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

EIN.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32360 | Film No.: 191182752
SIC: 2834 Pharmaceutical Preparations